Cite

HARVARD Citation

    Charlton, P. et al. (n.d.). 60: Discontinuation of maintenance pemetrexed (mPEM) in non-small cell lung cancer (NSCLC) due to renal failure. Lung cancer. pp. S24-. [Online]. 
  
Back to record